BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

MILLENNIUM THE TAKEDA ONCOLOGY COMPANY — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

MILLENNIUM THE TAKEDA ONCOLOGY COMPANY

via THE VICTORY GROUP, INC.

3rd Quarter (July 1 - Sep 30) · 2012Posted Feb 5, 2013Filing document ↗LDA record ↗

Income$12Kfee reported

Client

Name: MILLENNIUM THE TAKEDA ONCOLOGY COMPANY
Description: Development of drugs for the treatment cancer.
Location: District of Columbia · United States of America

Registrant

Firm: THE VICTORY GROUP, INC.
Description: Government Relations & Lobbying
Location: Boston, Massachusetts, United States of America

Lobbying activities

1 issue

Health Issues
PUDFA, ACA, health care reform
Lobbyistsmr STEPHEN J MULLONEY
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.